Dr. Andrew L. Coveler
Claim this profileFred Hutchinson Cancer Research Center
Studies Pancreatic Cancer
Studies Pancreatic Adenocarcinoma
10 reported clinical trials
22 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
2Pancreatic Adenocarcinoma
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Andrew L. Coveler is currently running
SRF388 + Pembrolizumab
for Cancer
This trial tests CHS-388, a protein that blocks IL-27, in patients with severe cancers like kidney, liver, and lung cancer. The goal is to see if it helps the immune system fight cancer better.
Recruiting1 award Phase 134 criteria
FOLFIRINOX + 9-ING-41
for Pancreatic Cancer
The purpose of this study is to find out if an experimental drug will prevent metastatic pancreatic adenocarcinoma from becoming resistant to standard treatment for the disease. The names of the study drugs involved in this study are: * 9-ING-41 * Losartan * Ferumoxytol * FOLFIRINOX (made up of 4 different drugs): * 5-Fluorouracil (5-FU) * Oxaliplatin * Irinotecan * Leucovorin
Recruiting1 award Phase 2
More about Andrew L. Coveler
Clinical Trial Related4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Andrew L. Coveler has experience with
- Gemcitabine
- Pembrolizumab
- 9-ING-41
- Dose -mFOLFIRINOX
- Pamrevlumab
- Canakinumab And Spartalizumab
Breakdown of trials Andrew L. Coveler has run
Pancreatic Cancer
Pancreatic Adenocarcinoma
Solid Tumors
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew L. Coveler specialize in?
Andrew L. Coveler focuses on Pancreatic Cancer and Pancreatic Adenocarcinoma. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Andrew L. Coveler currently recruiting for clinical trials?
Yes, Andrew L. Coveler is currently recruiting for 3 clinical trials in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Andrew L. Coveler has studied deeply?
Yes, Andrew L. Coveler has studied treatments such as Gemcitabine, Pembrolizumab, 9-ING-41.
What is the best way to schedule an appointment with Andrew L. Coveler?
Apply for one of the trials that Andrew L. Coveler is conducting.
What is the office address of Andrew L. Coveler?
The office of Andrew L. Coveler is located at: Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 United States. This is the address for their practice at the Fred Hutchinson Cancer Research Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.